title: GLP-1R Agonists and Endothelial Dysfunction: More Than Just Glucose Lowering?
authors.affiliation: Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Julie
authors.initials: J
authors.lastname: Lovshin
authors.affiliation: Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada david.cherney@uhn.on.ca.
authors.forename: David
authors.initials: D
authors.lastname: Cherney
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D042783:Endothelial Cells / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D010455:Peptides / Q000494:pharmacology*; D018027:Receptors, Glucagon / Q000819:agonists*; D014664:Vasodilation / Q000187:drug effects*; D014688:Venoms / Q000494:pharmacology*
chemical_list: D010455:Peptides; D018027:Receptors, Glucagon; D014688:Venoms